Jason Davis has bought stock on 2 days since Jul 2017

Jason D. Davis, CPA is the Chief Financial Officer of FibroBiologics, Inc. (Nasdaq: FBLG), appointed effective June 9, 2025.( A seasoned finance executive with over 20 years of experience in public company finance, capital markets, and SEC reporting, Davis plays a critical role in the company's strategic financial decision-making as it advances its fibroblast-based therapeutics for chronic diseases.(

Davis previously served as CFO of Virax Biolabs, guiding the company through its IPO in July 2022, leading capital raises, managing SEC filings, and implementing governance practices.( Earlier, at HyperDynamics Corp., he significantly grew the market cap from $20 million to over $700 million and raised more than $200 million from U.S. and European markets.( He holds a B.B.A. in Accounting from the University of Houston and is a Certified Public Accountant in Texas.( On March 2, 2026, Davis purchased 70,000 shares of FBLG common stock in an open-market transaction at a weighted average price of $0.4139 per share.(

Written by Perplexity from public sources.